SPM-301

N/A

Report date: 2023/03/07 15:53:37
NME

Base Information

Drug NameSPM-301
Drug Alias NameSPM-301
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionMyc proto-oncogene protein degraders
TargetsMyc proto-oncogene protein
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSEngine Precision Medicine Inc
China Registration ClassN/A

Develop Information

Active CompaniesSEngine Precision Medicine Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A